Australia markets closed

ABBV Jun 2024 90.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
48.350.00 (0.00%)
As of 02:53PM EST. Market open.
Full screen
Previous close48.35
Open48.35
Bid60.55
Ask61.75
Strike90.00
Expiry date2024-06-21
Day's range48.35 - 48.35
Contract rangeN/A
Volume1
Open interest10
  • Bloomberg

    Bond Markets Are Flooded With Deals to Fund M&A

    (Bloomberg) -- Demand has grown so fervent for corporate bonds that investors are once again willing to finance big mergers and acquisitions — something they hesitated to do for much of last year.Most Read from BloombergBYD’s New $233,450 EV Supercar to Rival Ferrari, LamborghiniZelenskiy Says 31,000 Troops Killed as Ukraine Seeks US Aid Decision Within MonthNorwegian Cruise Ship Halted at Mauritius Due to OutbreakJack Ma-Backed Ant Outbids Citadel Securities for Credit Suisse’s China JVRisk Mod

  • Zacks

    Pharma Stock Roundup: Pfizer's Velsipity Receives EU Nod, ABBV Gets New CEO & More

    European Commission approves Pfizer's (PFE) Velsipity ulcerative colitis (UC) pill. AbbVie (ABBV) appoints Robert A. Michael as the new CEO.

  • Bloomberg

    AbbVie Sells $15 Billion of Bonds to Buy ImmunoGen, Cerevel

    (Bloomberg) -- Pharmaceutical giant AbbVie Inc. sold $15 billion of bonds in the US investment-grade market on Thursday to help fund its acquisitions of ImmunoGen Inc. and Cerevel Therapeutics Holdings Inc., adding to a recent rush of buyout financings. Most Read from BloombergNvidia Rises Most in About Nine Months as AI Drives SalesT-Bills Without Tax Bills? This Fund Says It Cracked the CodeStocks Rally as AI Craze Sweeps Across the World: Markets WrapAT&T Outage Triggered by Company Work on N